Clinical Trials

15 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT07590856 2026-05-15

A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33

Colorectal Neoplasms

NCT07586709 2026-05-14

In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms

18 enrolled

Neoplasms, Plasma Cell

NCT07583953 2026-05-13

An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors

Other solid neoplasm

Solid Tumors

NCT07584850 2026-05-13

Evaluation of GI001 for Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

9 enrolled

Lymphoma, B-Cell

NCT07577999 2026-05-11

The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy

Non-metastatic Bladder Cancer

NCT07574346 2026-05-07

IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies

18 enrolled

Neoplasms, Recurrence

NCT07568366 2026-05-05

AI in Endoscopic Transsphenoidal Surgery

Endocrine

Pituitary Neoplasms

NCT07563543 2026-05-04

RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Lymphoma, B-Cell

NCT05728879 2026-05-01

Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT07563023 2026-05-01

Exploratory Study on the Treatment of EB Virus Positive HIV Associated Lymphoma With EBV mRNA Vaccine

6 enrolled

Lymphoma, Primary Effusion

NCT07558538 2026-04-30

Clinical Trial of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

Lymphoma, Follicular, Acute Lung Injury

NCT07546630 2026-04-29

Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy of Relapsed/Refractory B-Cell Lymphoma

Lymphoma, B-Cell

NCT07556653 2026-04-29

WTX-212C-IIT

Other solid neoplasm

Advanced Solid Tumors

NCT07553767 2026-04-28

Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection

156 enrolled

Hepatitis B, Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT05676489 2026-04-27

MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors

28 enrolled

CNS

Glioma

NCT07389525 2026-04-24

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

DermatologicGastrointestinalSarcoma

80 enrolled

Gastrointestinal Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms

NCT07487402 2026-04-21

Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma

27 enrolled

Carcinoma, Hepatocellular

NCT07542379 2026-04-21

The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer

13 enrolled

Prostatic Neoplasms

NCT07539233 2026-04-20

A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019B in Patients With Relapsed/Refractory Multiple Myeloma.

Multiple Myeloma

NCT07519187 2026-04-09

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

Recurrence, Neoplasms, Plasma Cell

NCT06986434 2026-04-08

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

LymphoidPlasma cell

Lymphoma, Recurrence, Neoplasms, Plasma Cell

NCT07516704 2026-04-08

Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study

94 enrolled

Prostatic Neoplasms

NCT07515924 2026-04-07

Oral Gallium Maltolate for Recurrent Glioblastoma

8 enrolled

CNS

Glioblastoma

NCT07286318 2026-04-02

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

NCT07498439 2026-03-27

TILs Therapy for Multiple Primary Early-Stage NSCLC

Thoracic

Primary Early-stage Non-small Cell Lung Cancer

NCT07498595 2026-03-27

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07493447 2026-03-25

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

CNSEndocrine

Brain Neoplasms, Glioblastoma, Meningioma, Neoplasms, Neuroma, Acoustic, Pituitary Neoplasms

NCT07489625 2026-03-24

Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain

Cancer Pain

NCT07486492 2026-03-20

Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer

Colorectal Cancer Metastatic

NCT07476027 2026-03-17

Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07039760 2026-03-11

Asciminib With or Without Sildenafil for Brain Tumors

12 enrolled

CNS

Brain Neoplasms

NCT07459283 2026-03-10

The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

BreastHead & NeckSarcoma

Breast Neoplasms, Head and Neck Neoplasms, Sarcoma, Thyroid Neoplasms

NCT07460232 2026-03-10

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT07458659 2026-03-09

CART-BCMA

3 enrolled

Multiple Myeloma

NCT07458919 2026-03-09

Therapy for Advanced NSCLC With EGFR 19delins Mutation

94 enrolled

Thoracic

Lung Neoplasms

NCT07429071 2026-03-04

Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.

70 enrolled

Gynecologic

Uterine Cervical Dysplasia

NCT07420036 2026-03-03

SFB6-ZN01 PET

98 enrolled

Hypersensitivity, Neoplasms

NCT07446257 2026-03-03

THIO and Cadonilimab in Resectable Hepatocellular Carcinoma

60 enrolled

Carcinoma, Hepatocellular

NCT07446686 2026-03-03

Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer

Breast

Breast Neoplasms

NCT07038278 2026-02-27

5-ALARMS

Sarcoma

NCT07318389 2026-02-27

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

100 enrolled

Colorectal Neoplasms

NCT07439120 2026-02-27

Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors

Carcinoma, Transitional Cell

NCT07416682 2026-02-25

CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms

High-risk Plasma Cell Neoplasms

NCT07429721 2026-02-24

A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.

Multiple Myeloma

NCT07408193 2026-02-20

The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.

Cancer Pain, Opioid-Related Disorders, Neoplasms

NCT07420010 2026-02-19

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

GastrointestinalGynecologicOther solid neoplasmThoracic

Colonic Neoplasms, Mesothelioma, Ovarian Neoplasms

NCT07412665 2026-02-17

A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

Other solid neoplasm

Advanced Solid Tumors

NCT07409766 2026-02-13

A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors